Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101928100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CTTNBP2NL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARPC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCAF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM39A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPOLG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD209 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MIR3945HG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMOC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AZIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMYM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on